SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 134 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,580 | -11.8% | 241,337 | 0.0% | 0.01% | -7.7% |
| Q2 2023 | $6,328 | +1.9% | 241,337 | 0.0% | 0.01% | -13.3% |
| Q1 2023 | $6,212 | -1.0% | 241,337 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $6,277 | -99.9% | 241,337 | 0.0% | 0.02% | -16.7% |
| Q3 2022 | $6,885,000 | +15.9% | 241,337 | 0.0% | 0.02% | +20.0% |
| Q2 2022 | $5,942,000 | -56.4% | 241,337 | 0.0% | 0.02% | -48.3% |
| Q1 2022 | $13,621,000 | -8.9% | 241,337 | 0.0% | 0.03% | -3.3% |
| Q4 2021 | $14,958,000 | -2.3% | 241,337 | 0.0% | 0.03% | -9.1% |
| Q3 2021 | $15,310,000 | -23.0% | 241,337 | 0.0% | 0.03% | -23.3% |
| Q2 2021 | $19,889,000 | -5.6% | 241,337 | -15.7% | 0.04% | -14.0% |
| Q1 2021 | $21,066,000 | -12.9% | 286,337 | -14.1% | 0.05% | -21.9% |
| Q4 2020 | $24,174,000 | +52.1% | 333,337 | 0.0% | 0.06% | +36.2% |
| Q3 2020 | $15,890,000 | -10.2% | 333,337 | -20.9% | 0.05% | -16.1% |
| Q2 2020 | $17,694,000 | +55.6% | 421,282 | 0.0% | 0.06% | +21.7% |
| Q1 2020 | $11,375,000 | – | 421,282 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |